ALIGN-AR Trial: Initial Outcomes of the JenaValve Trilogy Transcatheter Aortic Valve Replacement in High Risk Patients With Symptomatic Severe Native Aortic Regurgitation

Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:

• Grant Support/Research Contract - Abbott; Edwards Lifesciences; Boston Scientific Corporation; Medtronic; artivion; JenaValve
• Consultant Fee/Honoraria/Speaker's Bureau - DASI Simulations; atricure